EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.

Biotechnology

Health Care

Therapeutics

EpiBiologics

Craig Lichtenstein

Shyra Gardai

Isaac J. Rondon

The Scientific Team at EpiBiologics is responsible for researching and developing innovative antibody-based therapies targeting membrane and extracellular proteins implicated in disease biology. Their work includes protein engineering, molecular biology, and bioinformatics to drive forward the discovery and optimization of novel treatment candidates.

Scientific Team

About

Team members

Other teams at EpiBiologics

Leadership Team